MIDDLE EAST AND AFRICA CRISPR MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

MIDDLE EAST AND AFRICA CRISPR MARKET 2021-2028

Market by Product, Application, Industry Verticals, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As assessed in Triton’s report, the CRISPR market in the Middle East and Africa is set to register growth based on revenue at a CAGR of 20.51% over the projected phase 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered for analysis in this market are:

•        The United Arab Emirates

•        Turkey

•        South Africa

•        Saudi Arabia

•        Rest of Middle East & Africa

In the Middle East and Africa, the public healthcare and agriculture sectors are estimated to benefit significantly from CRISPR, owing to the high prevalence of tropical diseases and pests. Moreover, the gene drives and other potential applications make CRISPR ideal for treating various genetic disorders in Africa, such as sickle-cell anemia. Further, recently, the region witnessed a massive drop in the number of crops due to high temperatures. As a result, scientists and plant breeders are developing new crop varieties that are high yielding and resistant to abiotic and biotic stresses like drought and insects, respectively. Thus, all these factors will drive the region’s CRISPR market’s growth.

Among the major countries, the UAE ranks sixth globally based on congenital disabilities caused mainly by genetic conditions. Moreover, several inherited diseases have been identified among the country’s population. Here, most of the genetic mutations have been clarified, helping develop accurate diagnostic tools and prevention strategies. Furthermore, researchers in the country have deployed gene-editing technology CRISPR-Cas9 to understand disease mechanisms that may offer new ways to develop novel therapies. Other than this, researchers have worked on familial hypercholesterolemia and disequilibrium syndrome, extending research in other genetic conditions. Hence, R&D activities are expected to propel the CRISPR market on a growth path across the UAE.

Editas Medicine is a transformative genome editing company involved in treating genetically defined diseases by correcting disease-causing genes. It operates across developing and commercializing genome editing technology segments. Besides, the company is developing a genome editing platform based on clustered and regularly interspaced palindromic repeats technology. It also serves clients in the Middle East and Africa region. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. MIDDLE EAST AND AFRICA CRISPR MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON CRISPR MARKET

2.2. KEY INSIGHTS

2.2.1. INDUSTRIAL BIOTECH IS THE FASTEST GROWING INDUSTRY VERTICAL

2.2.2. REWRITING OF GENETIC DISORDERS THROUGH GENOME SURGERY

2.2.3. INCREASING USAGE OF PROSPECTIVE APPLICATIONS OF CRISPR TECHNOLOGY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. PATENT OUTLOOK

2.7. FUNDING OUTLOOK

2.8. KEY IMPACT ANALYSIS

2.8.1. COST

2.8.2. ACCURACY

2.8.3. EASY TO USE

2.9. KEY MARKET STRATEGIES

2.9.1. ACQUISITIONS

2.9.2. PRODUCT LAUNCHES

2.9.3. CONTRACTS & PARTNERSHIPS

2.9.4. BUSINESS EXPANSIONS & DIVESTITURES

2.10. MARKET DRIVERS

2.10.1. GROWING LIFESTYLE-ORIENTED DISEASES

2.10.2. SURGING PREVALENCE OF GENETIC DISEASES

2.11. MARKET CHALLENGES

2.11.1. GROWING ETHICAL ISSUES REGARDING TECHNOLOGY USE

2.11.2. LIKELY MISUSE OF GENE-EDITING TOOL

2.11.3. ABSENCE OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES

2.12. MARKET OPPORTUNITIES

2.12.1. ADVANCEMENTS IN GENE-BASED THERAPY IN THE AGRICULTURAL SECTOR

2.12.2. INCREASED NEED FOR CLINICAL TRIALS

2.12.3. RISE IN AWARENESS ABOUT GENE THERAPEUTICS

3. MIDDLE EAST AND AFRICA CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.4. DESIGNING TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4. MIDDLE EAST AND AFRICA CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/GENETIC ENGINEERING

4.2. CRISPR PLASMID

4.3. HUMAN STEM CELLS

4.4. GRNA DATABASE/GENE LIBRARY

4.5. CELL LINE ENGINEERING

5. MIDDLE EAST AND AFRICA CRISPR MARKET OUTLOOK - BY INDUSTRY VERTICALS

5.1. THERAPEUTICS AND DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6. MIDDLE EAST AND AFRICA CRISPR MARKET – REGIONAL OUTLOOK

6.1. UNITED ARAB EMIRATES

6.2. SAUDI ARABIA

6.3. TURKEY

6.4. SOUTH AFRICA

6.5. REST OF MIDDLE EAST & AFRICA

7. COMPETITIVE LANDSCAPE

7.1. ADDGENE

7.2. CARIBOU BIOSCIENCES INC

7.3. CELLECTIS BIORESEARCH SAS

7.4. CRISPR THERAPEUTICS AG

7.5. EDITAS MEDICINE

7.6. GENSCRIPT

7.7. HORIZON DISCOVERY GROUP

7.8. INTEGRATED DNA TECHNOLOGIES

7.9. INTELLIA THERAPEUTICS

7.10. LONZA GROUP LTD

7.11. NEW ENGLAND BIOLABS

7.12. NOVARTIS INTERNATIONAL AG

7.13. ORIGENE TECHNOLOGIES INC

7.14. PRECISION BIOSCIENCES

7.15. SYNTHEGO CORPORATION

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: MIDDLE EAST AND AFRICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)      

TABLE 2: VENDOR SCORECARD        

TABLE 3: FUNDING OUTLOOK OF PUBLIC COMPANIES  

TABLE 4: FUNDING OUTLOOK OF PRIVATE COMPANIES

TABLE 5: FUNDING OUTLOOK OF GOVERNMENT ORGANIZATIONS   

TABLE 6: MIDDLE EAST AND AFRICA CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)      

TABLE 7: MIDDLE EAST AND AFRICA CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)      

TABLE 8: MIDDLE EAST AND AFRICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)          

TABLE 9: MIDDLE EAST AND AFRICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)       

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX       

FIGURE 2: FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION         

FIGURE 3: KEY IMPACT ANALYSIS     

FIGURE 4: MIDDLE EAST AND AFRICA CRISPR MARKET, BY PRODUCT, 2020 & 2028 (IN %)           

FIGURE 5: MIDDLE EAST AND AFRICA CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)      

FIGURE 6: MIDDLE EAST AND AFRICA CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)      

FIGURE 7: MIDDLE EAST AND AFRICA CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)      

FIGURE 8: MIDDLE EAST AND AFRICA CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)        

FIGURE 9: MIDDLE EAST AND AFRICA CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)           

FIGURE 10: MIDDLE EAST AND AFRICA CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)   

FIGURE 11: MIDDLE EAST AND AFRICA CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)      

FIGURE 12: MIDDLE EAST AND AFRICA CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)        

FIGURE 13: MIDDLE EAST AND AFRICA CRISPR MARKET, BY APPLICATION, 2020 & 2028 (IN %)      

FIGURE 14: MIDDLE EAST AND AFRICA CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)      

FIGURE 15: MIDDLE EAST AND AFRICA CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)        

FIGURE 16: MIDDLE EAST AND AFRICA CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)          

FIGURE 17: MIDDLE EAST AND AFRICA CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)     

FIGURE 18: MIDDLE EAST AND AFRICA CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)

FIGURE 19: MIDDLE EAST AND AFRICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)  

FIGURE 20: MIDDLE EAST AND AFRICA CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2021-2028 (IN $ MILLION)          

FIGURE 21: MIDDLE EAST AND AFRICA CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 22: MIDDLE EAST AND AFRICA CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)

FIGURE 23: MIDDLE EAST AND AFRICA CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)          

FIGURE 24: MIDDLE EAST AND AFRICA CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)  

FIGURE 25: UNITED ARAB EMIRATES CRISPR MARKET 2021-2028 (IN $ MILLION)  

FIGURE 26: SAUDI ARABIA CRISPR MARKET 2021-2028 (IN $ MILLION)          

FIGURE 27: TURKEY CRISPR MARKET 2021-2028 (IN $ MILLION)          

FIGURE 28: SOUTH AFRICA CRISPR MARKET 2021-2028 (IN $ MILLION)        

FIGURE 29: REST OF MIDDLE EAST & AFRICA CRISPR MARKET 2021-2028 (IN $ MILLION)            

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying